CHELSEA THERAPEUTICS INTL LT's ticker is and the CUSIP is 163428905. A total of 2 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $0 | -100.0% | 26,700 | -90.1% | 0.00% | -100.0% |
| Q1 2014 | $1,482,000 | +2.1% | 268,500 | -17.9% | 0.02% | +13.6% |
| Q4 2013 | $1,451,000 | +359.2% | 327,100 | +209.8% | 0.02% | +266.7% |
| Q3 2013 | $316,000 | +2006.7% | 105,600 | +1500.0% | 0.01% | – |
| Q2 2013 | $15,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 327,100 | $1,451,000 | 0.02% |
| Citadel Advisors | 31,400 | $139,000 | 0.00% |